🇺🇸
United States · US · US:71894-200_ab2e1c6c-4f95-4243-9296-1734e0a30591
ITVISMA
UNIISPLATC M09AX09
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerNovartis Gene Therapies, Inc.
CountryUS (United States)
ATC codeM09AX09
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1171894200021 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1 VIAL, SINGLE-DOSE (71894-200-01)
Annotations
UNII (FDA Substance ID)
MLU3LU3EVV
ONASEMNOGENE ABEPARVOVEC
RxCUI 2170226
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "MLU3LU3EVV",
"rxcui": "2170226",
"inchikey": null,
"display_name": "ONASEMNOGENE ABEPARVOVEC",
"substance_type": "structurallyDiverse",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRATHECAL",
"spl_meta": {
"ab2e1c6c-4f95-4243-9296-1734e0a30591": {
"match": "brand_token",
"title": "ITVISMA (ONASEMNOGENE ABEPARVOVEC-BRVE) INJECTION, SUSPENSION [NOVARTIS GENE THERAPIES, INC.]",
"spl_version": "1",
"published_date": "2025-11-27"
}
},
"productid": "71894-200_ab2e1c6c-4f95-4243-9296-1734e0a30591",
"productndc": "71894-200",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ONASEMNOGENE ABEPARVOVEC",
"proprietary_name": "ITVISMA",
"active_ingred_unit": "[arb'U]/mL",
"application_number": "BLA125856",
"marketing_category": "BLA",
"nonproprietary_name": "onasemnogene abeparvovec-brve",
"start_marketing_date": "20251124",
"active_numerator_strength": "40000000000000"
}Related drugs
Other records sharing ATC code M09AX09.
Access this data programmatically
Query ITVISMA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.